BioMarin reports five-year Pompe disease data showing durable motor function

2 hours ago

Why Lilly and Novo are betting on amylin to power new obesity drugs after GLP-1s

2 hours ago

Big Pharma's China deal spree grows with latest tie-up worth up to $7.8 billion

6 hours ago

De-risking rare disease drug development

7 hours ago

Micron drops despite 'a great quarter.' Why Cramer is sticking with the stock

1 day ago

$942 million: Insurer points finger at AI as suspect hospital charges appear

1 day ago

Grindr expands beyond dating with $250 million PurposeMed acquisition

1 day ago

Eli Lilly says closely watched combo obesity regimen boosts weight loss in trial

1 day ago

Novo's Wegovy pill improves weight loss after people switch from injections

2 days ago

White House moves to block $810 million in funding through pocket rescission

6 days ago

Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s

7 days ago

NIH cuts delayed a cancer trial. Patients lost time they didn't have

7 days ago

Why we like Starbucks' latest turnaround move — plus, two more wins for Eli Lilly

7 days ago

Novo's new strategy hinges on something it can't manufacture: investor trust

8 days ago

Trump administration removes around 760,000 Obamacare enrollments

8 days ago

Eli Lilly CEO says 700,000 seniors have started GLP-1s after Medicare coverage

9 days ago

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo

11 days ago

Why more companies are fighting over beauty, health and wellness spending

11 days ago

Mitch McConnell returns to Senate after three-month health absence

17 days ago

Athletes with autism take center court at the US Open

18 days ago

Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' strategy

18 days ago

Record U.S. cyclosporiasis outbreak is over, CDC says

21 days ago

A rapid-fire update on our 33-stock portfolio, including 6 stocks to buy now

21 days ago

Rare disease is taking his vision. A gene therapy could help — if he can get it

22 days ago

Jim Cramer says investors are too focused on AI stocks. Here's where he says to look instead

23 days ago

'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat

24 days ago

AstraZeneca's COPD drug shows late-stage trial wins, boosts blockbuster hopes

24 days ago

Pharma major Novartis falls 10% after three drug trial setbacks

24 days ago

Cholesterol drug setback casts doubt over multibillion-dollar race

24 days ago

Billionaire family offices back healthcare and biotech startups in August

29 days ago

Cramer: Here are 3 defensive stock market moves I'm making as oil and rates surge

1 month ago

We're adding 2 stocks to our Bullpen watchlist because they meet these criteria

1 month ago